Is ABEO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ABEO. It does not provide personalized investment advice.

ABEO (Abeona Therapeutics Inc. Common Stock) Stock Analysis - Financials

Abeona Therapeutics Inc. Common Stock (ABEO) is a publicly traded Healthcare sector company. As of September 22, 2026, ABEO trades at $5.69 with a market cap of $318.51M and a P/E ratio of -3.62. ABEO moved +1.89% today. Year to date, ABEO is +7.59%; over the trailing twelve months it is +5.39%. Its 52-week range spans $3.93 to $7.65. Analyst consensus is strong buy with an average price target of $22.00. Rallies surfaces ABEO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ABEO's key financials?

ABEO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ABEO recently traded at $5.69. Market cap is $318.51M. P/E ratio is -3.62. Revenue is $0.

ABEO Key Metrics

Key financial metrics for ABEO
Metric	Value
Price	$5.69
Market Cap	$318.51M
P/E Ratio	-3.62
EPS	$-1.55
Dividend Yield	0.00%
52-Week High	$7.65
52-Week Low	$3.93
Volume	912.46K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-63.73M
Gross Margin	0.00%

ABEO Analyst Consensus

4 analysts cover ABEO: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.00.

Common questions about ABEO

What are ABEO's key financials?: ABEO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ABEO recently traded at $5.69. Market cap is $318.51M. P/E ratio is -3.62. Revenue is $0.
Is ABEO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ABEO. It does not provide personalized investment advice.